imc medical cannabis: Successful brand launch for adjupharm.
In Israel, IMC has long been recognised as a premium brand for medical cannabis. In 2020, IM Cannabis Corp. successfully launched its brand on the German market through its subsidiary, adjupharm GmbH, based in Bad Oldesloe.
The market for medical cannabis is still in its early stages and hampered by uncertainty among patients, physicians and pharmacists. The stigma of cannabis use, the lack of knowledge about treatment options as well as the prescription and billing regulations are currently still hindering the widespread use of cannabis in Germany. We want to change that.
In the course of the brand launch, we developed and designed various communication tools for imc. In an omnichannel approach, we managed analogue and digital channels and positioned the brand as an expert on all topics related to the use of medical cannabis.